


Package Leaflet: Information for the Patient
Viatris Alfuzosin 10 mg prolonged-release tablets EFG
Alfuzosin hydrochloride
For adult men
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Viatris Alfuzosin contains the active substance alfuzosin hydrochloride, which belongs to a group of medicines called alpha-adrenergic receptor antagonists or alpha-blockers.
Viatris Alfuzosin is used to treat the symptoms of benign prostatic hyperplasia (a non-cancerous enlargement of the prostate gland). The prostate gland is located beneath the bladder, surrounding the urethra. If the prostate gland enlarges, it can put pressure on the urethra, making it narrower. An enlarged prostate gland can cause urinary problems such as frequent and difficult urination, especially at night.
Alpha-blockers relax the muscles in the prostate and the neck of the bladder, making it easier for urine to flow out of the bladder.
In some patients with benign prostatic hyperplasia, the prostate gland becomes so enlarged that it completely blocks the flow of urine. This is called acute urinary retention. It is very painful and you may need to stay in the hospital for a short time. A thin, flexible tube (catheter) is inserted into the bladder to drain the urine and relieve the pain. Alfuzosin can be used to help the urine flow again.
Do not take Viatris Alfuzosin:
Do not take this medicine if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking alfuzosin.
Warnings and precautions
Talk to your doctor or pharmacist before taking Viatris Alfuzosin.
When taking this medicine, you may experience a sudden drop in blood pressure when standing up (you may feel dizzy, tired, weak, or sweaty), especially in the first few hours after taking Viatris Alfuzosin. If you experience low blood pressure, you should remain lying down with your legs and feet elevated until the symptoms disappear. Usually, these effects are short-lived and occur at the start of treatment. Normally, it is not necessary to stop treatment. Inform your doctor as they may decide to adjust your dose.
In case of an erection (often painful) that is not related to sexual activity and lasts for more than 4 hours, you should contact a doctor or go to the hospital immediately because you may need treatment. See the section below "Possible side effects".
If you need to undergo eye surgery for cataracts (clouding of the lens in the eye), please inform your ophthalmologist before the operation if you are taking or have taken Viatris Alfuzosin in the past. This is because Viatris Alfuzosin may cause complications during the operation, which can be taken into account and controlled by your ophthalmologist if they have been informed beforehand.
Children and adolescents
Viatris Alfuzosin is not recommended for use in children and adolescents (patients under 16 years of age).
Taking Viatris Alfuzosin with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
Do not take Viatris Alfuzosin if you are taking other medicines of the same type as this medicine, known as alpha-blockers, such as doxazosin, indoramin, terazosin, prazosin, or tamsulosin.
Viatris Alfuzosin may affect the action of other medicines. Tell your doctor or pharmacist if you are taking any of the following medicines:
If you are going to undergo an operation that requires general anesthesia, inform your doctor or the hospital staff that you are taking this medicine. Your doctor may advise you to stop taking this medicine 24 hours before the operation to prevent the risk of changes in blood pressure.
Pregnancy and breastfeeding
Viatris Alfuzosin is only indicated for use in men.
Viatris Alfuzosin with food and drinks
Take alfuzosin after meals.
Driving and using machines
Especially at the start of treatment, Viatris Alfuzosin may cause dizziness, drowsiness, or weakness. Do not drive, operate machinery, or perform hazardous tasks until you know how your body reacts to this medicine.
Viatris Alfuzosin contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Always take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
How much to take
Benign Prostatic Hyperplasia
Acute Urinary Retention
Swallow the tablet whole with a sufficient amount of liquid. Do not crush, chew, or break the tablets, as too much of the active ingredient alfuzosin may enter your body too quickly. This could increase the risk of side effects.
If you have kidney problems
If you have moderate or severe kidney disease, your doctor may recommend that you start with a lower dose of alfuzosin. If a lower dose does not work, your doctor may recommend that you take one tablet (10 mg of alfuzosin) once a day. Take the tablet after dinner.
If you take more Viatris Alfuzosin than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you take too much Viatris Alfuzosin, you may experience a sudden drop in blood pressure and may feel dizzy or even faint. If you start to feel dizzy, sit or lie down until you feel better. If the symptoms do not disappear, call your doctor as this drop in blood pressure should be treated in a hospital. Do not drive yourself to the hospital.
If you forget to take Viatris Alfuzosin
Do not take a double dose to make up for forgotten doses, as this may cause a sudden drop in blood pressure. Take the next tablet as directed.
If you stop taking Viatris Alfuzosin
Do not stop or discontinue treatment with alfuzosin without consulting your doctor first.
If you want to stop treatment or have any other questions about the use of this medicine, ask your doctor or pharmacist.
Use in children
Alfuzosin is not indicated for use in children.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following side effects, stop taking this medicine and contact your doctor or go to the emergency department of the nearest hospital immediately:
Other possible side effects
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(frequency cannot be estimated from the available data):
If you are going to undergo eye surgery for cataracts (clouding of the lens in the eye) and are already taking or have taken alfuzosin in the past, the pupil may not dilate properly and the iris (the colored part of the eye) may become flaccid during the procedure. This only happens during the operation and it is important that the ophthalmologist is informed as they may need to perform the operation differently (see "Warnings and precautions").
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Vigilance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Do not store above 30°C.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and on the carton after EXP. The expiry date is the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to a pharmacy for disposal. If you are unsure, ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Viatris Alfuzosin
The active substance is alfuzosin hydrochloride. Each prolonged-release tablet contains 10 mg of alfuzosin hydrochloride.
The other ingredients are: lactose monohydrate, hypromellose, povidone, and magnesium stearate.
Appearance and packaging
Viatris Alfuzosin 10 mg are white, round, prolonged-release tablets with beveled edges and no coating.
They are available in blister packs of 10, 20, 30, 50, 60, 90, and 100 tablets and in perforated unit-dose blisters of 30 and 60 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder:
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer:
Mylan Hungary Kft.
H-2900 Komárom
Mylan utca 1
Hungary
You can request more information about this medicine from the local representative of the marketing authorisation holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medicine is authorised in the Member States of the European Economic Area under the following names:
Denmark Lafunomyl 10 mg
Austria Alfuzosin ’Arcana’ 10 mg Retardtabletten
Belgium Alfuzosine Mylan 10 mg
Czech Republic Alfuzosin Mylan 10 mg
Finland Lafunomyl 10 mg
Spain Alfuzosina Viatris 10 mg prolonged-release tablets EFG
Hungary Alfugen 10 mg
Ireland Xatger 10 mg prolonged release tablet
Italy Alfuzosina Mylan 10 mg
Netherlands Alfuzosine HCl Retard Mylan 10 mg, tabletten met gereguleerde afgifte
Poland Alugen 10 mg
Portugal Alfuzosina Mylan 10 mg
Sweden Lafunomyl 10 mg
Slovakia Alfuzosin Mylan 10 mg
United Kingdom (Northern Ireland) Taurazil SR 10 mg Tablets
Date of last revision of this leaflet: December 2021
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of ALFUZOSIN VIATRIS 10 mg PROLONGED-RELEASE TABLETS in November, 2025 is around 11.8 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ALFUZOSIN VIATRIS 10 mg PROLONGED-RELEASE TABLETS – subject to medical assessment and local rules.